# Examining the Effect of Ondansetron on Bowel Prep Success

> **NCT05439772** · PHASE4 · COMPLETED · sponsor: **State University of New York - Downstate Medical Center** · enrollment: 41 (actual)

## Conditions studied

- Abdominal Pain
- Inflammatory Bowel Diseases
- Eosinophilic Gastroenteritis
- Diarrhea
- Hematochezia
- Weight Loss

## Interventions

- **DRUG:** Ondansetron

## Key facts

- **NCT ID:** NCT05439772
- **Lead sponsor:** State University of New York - Downstate Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05439772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05439772, "Examining the Effect of Ondansetron on Bowel Prep Success". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05439772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*